Wave life sciences to present at chardan's 6th annual genetic medicines conference

Cambridge, mass., sept. 27, 2022 (globe newswire) -- wave life sciences ltd. (nasdaq: wve), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that paul bolno, md, mba, president and chief executive officer, is scheduled to participate in an analyst-led fireside chat at the chardan's 6th annual genetic medicines conference in new york city on tuesday, october 4, 2022, at 3:15 p.m. et.
WVE Ratings Summary
WVE Quant Ranking